Cancer Research UK logo.
SearchDonate
  • Search

A trial of olaparib with radiotherapy and chemotherapy for glioblastoma (PARADIGM-2)

Overview

Cancer types:

Brain (and spinal cord) tumours

Status:

Closed

Phase:

Phase 1

Details

This trial is looking at whether a drug called olaparib improves the way radiotherapy and chemotherapy work. It is for people with a type of brain tumour called glioblastoma who:

  • are newly diagnosed

  • have recently had surgery

Cancer Research UK supports this trial.

Recruitment start: 15 November 2016

Recruitment end: 31 December 2024

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Anthony Chalmers

Supported by

Cancer Research UK

AstraZeneca

NHS Greater Glasgow and Clyde

The Brain Tumour Charity

University of Glasgow

Other information

This is Cancer Research UK trial number CRUKD/16/010.

Last reviewed: 2 January 2025

CRUK internal database number: 14194

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.